trending Market Intelligence /marketintelligence/en/news-insights/trending/_z9aim18fvetfjukmxtaha2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Pivot Pharmaceuticals replaces board chairman

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Pivot Pharmaceuticals replaces board chairman

Pivot Pharmaceuticals Inc. said Ahmad Doroudian will step down as executive chairman of the board.

Doroudian was previously CEO and director of the Canadian company and will remain as an adviser and a significant shareholder.

The biopharmaceutical company appointed Joseph Borovsky as its new chairman, who will also continue in his previous role as executive vice president of product development.